It was reported that DHM inhibited lipid accumulation in hepatocytes by activating AMPK/PGC-1α/estrogen related receptor α signaling to increase SIRT3 expression and reduce oxidative stress, thereby preventing the development of NAFLD (Zeng et al., 2019). This evidence concerns the gene SIRT3 and metabolic dysfunction-associated steatotic liver disease.